1-7 of 7
Thomas Loughran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia

Clinical Trials & Observations
Jonathan E. Brammer, Karen Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura, Anjali Mishra, Eric M. McLaughlin, David Feith, Nazli Azimi, Thomas A. Waldmann, Yutaka Tagaya, Thomas Loughran
Journal: Blood
Blood (2023) 142 (15): 1271–1280.
https://doi.org/10.1182/blood.2022017643
Published: 2023
Includes: Supplemental data
Journal Articles

KLRG1 Depletion Is a Novel Therapeutic Strategy for Patients with Mature T and NK/T-Cell Lymphomas

Bimarzhan Assatova, Christopher Trevisani, Robert Willim, Jessica Duffy, Abner Louissaint, Jr., Won-Seog Kim, David J Feith, Thomas Loughran, Jr., Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Garrett Haskett, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B. Heavican-Foral, Nora Scanlan, Gail Newton, Jaehyuk Choi, Jeffrey A Barnes, Patrick Connor Johnson, Eric D Jacobsen, Steven Greenberg, David M. Weinstock, Salvia Jain
Journal: Blood
Blood (2022) 140 (Supplement 1): 2253–2255.
https://doi.org/10.1182/blood-2022-162583
Published: 2022
Journal Articles

Permissive Conditions for Evolution of PNH Clones Are Characterized by Overproduction of IFN-γ by Clonal CD4 and CD8 T Cells, Fas-L by CTLs, and Promoted by Immunogenetic Background

Michael Clemente, Heather Cazzolli, Anna Jankowska, Christine O’Keefe, Bianca Serio, Susan Nyland, Marcin Wlodarski, PK Epling-Burnette, Thomas Loughran, Alan List, Ronald Paquette, Jaroslaw Maciejewski
Journal: Blood
Blood (2008) 112 (11): 4116.
https://doi.org/10.1182/blood.V112.11.4116.4116
Published: 2008
Journal Articles

Preliminary Results from a Phase I Study of Revlimid® (Lenalidomide) in Combination with Vidaza® (Azacitidine) in Patients with Advanced Myelodysplastic Syndromes (MDS).

Mikkael A. Sekeres, MD, MS, Alan List, MD, David Cuthbertson, MS, Ronald Paquette, MD, Thomas Loughran, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1458.
https://doi.org/10.1182/blood.V110.11.1458.1458
Published: 2007
Journal Articles

MICA Polymorphism Identified by Whole Genome Array Constitutes a Disease Predisposition Factor in T-Cell Large Granular Lymphocyte Leukemia.

Aaron D. Viny, BS, Hemant Ishwaran, PhD, Andrew Dunbar, BA, Bartlomiej Przychodzen, Thomas Loughran, Jr., MD, Jaroslaw P. Maciejewski, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 3304.
https://doi.org/10.1182/blood.V110.11.3304.3304
Published: 2007
Journal Articles

Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.

Aaron D. Viny, BS, Alan Lichtin, M.D., Brad Pohlman, M.D., Zachary Nearman, B.S., Thomas Loughran, Jr., M.D., Jaroslaw P. Maciejewski, M.D./Ph.D
Journal: Blood
Blood (2007) 110 (11): 4675.
https://doi.org/10.1182/blood.V110.11.4675.4675
Published: 2007
Journal Articles

Pathologic Clonal CTLResponses - Non Random Nature of the TCR Restriction in LGL Leukemia.

Marcin W. Wlodarski, Christine O’Keefe, Ph.D., Evan Howe, Alexander Rodriquez, Thomas Loughran, M.D., Jaroslaw P. Maciejewski, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3241.
https://doi.org/10.1182/blood.V104.11.3241.3241
Published: 2004